1979; Burger et al. 1981) . The different accessibility of adjacent deoxyribose rings to the propyl-EDTA.Fe(II) moiety in the unprotected site bound by MPE might result in asymmetric footprints on opposite DNA strands. From model building with right-handed, double-helical DNA and MPE.Fe(II), we expect the footprint on each DNA strand to be shifted at least 1 bp to the 3' side of the drug-binding site (Fig. 2) . Greater precision in identifying the boundaries of the preferred drug-binding sites would be afforded by an analysis of opposite strands.
We report here complementary-strand analyses of distamycin and actinomycin binding on heterogeneous DNA using the MPE-Fe(II) footprinting technique. Two DNA restriction fragments, 117 bp and 168 bp in length, each containing regions of identical sequence, were prepared with 3' -end labeling on complementary strands. DNA-cleavage inhibition patterns resulting from MPE.Fe(II) cleavage of the drug-protected DNA restriction fragments provide the opposite-strand footprints (Fig.  3 ). This affords a more precise location of the preferred binding sites on 50 bp of heterogeneous DNA for distamycin and actinomycin.
MATERIALS AND METHODS
Actinomycin D was obtained from Merck, Sharpe, and Dohme. Distamycin A was obtained from Boehringer Mannheim. Dithiothreitol (DTT) was obtained from Calbiochem. Ferrous ammonium sulfate, Fe(NH4)2-(SO4h'6H20, was obtained from Baker. MPE was synthesized and purified by procedures already described . The plasmid pLJ3, constructed by L. Johnsrud (Harvard University), was a generous girl from D. Galas (University of California, Los Angeles). Solutions of Fe(NH4)2(SO4)2.6H20, DTT, and MPE were freshly prepared. Concentrations of MPE, actinomycin, and distamycin were determined spectroscopically. Reactions (10 #l final volume) contained 10 mM Tris-HCl (pH 7.8) and 50 mM NaCl. Each reaction mixture contained more than 600 cpm of DNA labeled on the 3' end with 32p, and the final concentration of DNA base pairs was brought up to 100 #M by the addition of sonicated, deproteinated calf thymus DNA. When present, final concentrations were l0 #M MPE, l0 #M Fe(II), and 4 mM DTT. Actinomycin and distamycin concentrations were adjusted (l-100 #M) as specified in Figure 5 . For footprinting, a solution of buffered DNA was incubated for 30 minutes at 20~ with either actinomycin or distamycin. The reaction was initiated by the addition of MPE-Fe(II) followed by DTT. The reaction was allowed to run at 37~ for 15 minutes, stopped by freezing in dry ice, and then lyophilized and resuspended in formamide loading buffer for gel electrophoresis (Maxam and Gilbert 1980) .
Preparation of specific, labeled DNA fragments.
DNA for this investigation consisted of a sequenced segment of the lactose operon in Escherichia coli. This was isolated from the plasmid pLJ3 grown in E. coli strain MM294. Part of this plasmid is a 285-bp insert containing two copies of the lactose operon promoter-operator sequence in the same orientation. A schematic diagram of the insert is shown in Figure 3 . Milligram quantities of the plasmid were isolated by procedures similar to those of Tanaka and Weisblum (1974) . Superhelical pLJ3 plasmids were first digested with the restriction endonuclease EcoRI and then labeled on the 3' end with
[32p]dATP and the Klenow fragment of DNA polymerase I. A second enzymatic digest with the restriction endonuclease HaeIII yielded two end-labeled fragments, 117 bp and 168 bp in length. These were isolated by gel electrophoresis on a 5% polyacrylamide, 1:30 crosslinked, 4-mm-thick preparatory gel. Further recovery and purification followed procedures similar to those of Maxam and Gilbert (1980) .
Sequencing gels. Resolution of inhibition patterns
was achieved by electrophoresis on 8 % polyacrylamide, 1"20 cross-linked sequencing gels that were 0.4 mm thick, 40 cm long and contained 50% urea. Electrophoresis was carried out at 1000 V for 3.5 hours to sequence 100 nucleotides, beginning 20 nucleotides from the labeled 3' end. Autoradiography was carried out at -50~ without the use of an intensification screen.
Densitometry. An 8 x 10-inch copy of the original autoradiograph was scanned at 485 nm with the incident beam collimated to a width of 0.05 mm on a Cary 219 spectrophotometer. The data were recorded as absorbance relative to the film-base density and analyzed using an Apple microcomputer.
RESULTS
For an investigation of the sequence-specific DNAcleavage inhibition by actinomycin and distamycin with MPE.Fe(II), two DNA substrates were prepared. The 117-bp and 168-bp restriction fragments, each containing the lactose operon promoter-operator region, were prepared with the 3' ends labeled with 32p on complementary strands. MPE.Fe(II)/DTT was allowed to react with the 117-bp or 168-bp fragments alone (Fig. 4) and with the l l7-bp or 168-bp fragments preequilibrated with either actinomycin or distamycin (Fig.  5) . Partial cleavage by MPE.Fe(II) was stopped after 15 minutes by freezing, lyophilization, and resuspension in formamide buffer. The s2p-end-labeled DNA products were analyzed by denaturing 8% polyacrylamide/50% urea gel electrophoresis, which is capable of resolving DNA fragments differing in length by one nucleotide. 
Distamycin. Different concentrations of distamycin
(1 #M, 10/zM, and 100 ttM) were allowed to equilibrate with the 117-bp and 168-bp DNA fragments (100/~M 
DISCUSSION

Complementary-strand Footprints
In principle, an altered DNA-cleavage pattern could be the result of suppressed reaction at some sites, enhanced reaction at others, or a combination of both effects. Without ruling out the possibility of enhanced cleavage, we have interpreted the light regions on the autoradiograph as regions of reduced cleavage of DNA by MPE.Fe(II) due to the presence of bound drug. The light regions on the autoradiograph (Fig. 5) correspond to the valleys in the densitometer tracings (Figs. 6 and  7) , which, in turn, correspond to the black regions on opposite strands on the 50-bp sequence shown in Figures 8 and 9 .
We can see from complementary-strand analysis that the footprints are asymmetric for both actinomycin and distamycin. The footprints appear to be shifted 1-2 bp to the 3' side on each strand and 1 bp underprotected on the 5' side. These data are consistent with the model (Fig. 2) . With this knowledge, we can now interpret the footprint and assign the preferred binding sites of actinomycin and distamycin with greater confidence. In addition, single-strand analyses of MPE footprinting of actinomycin and distamycin on other DNA restriction fragments become amenable to interpretation (Van Dyke et al. 1982) .
The 50-bp sequence that afforded the complementarystrand analysis is composed of 44% dG.dC and 56% dA.dT. We can identify 24 bp protected by the minorgroove binder distamycin out of 50 bp, which corresponds to 48% saturation (Fig. 10) . Of the 24 bp protected by distamycin, 20 bp (83%) are dA.dT. The minimum protected region observed is the 4-bp sequence, 5' AATT 3'. For a binding-site size of 4 bp, the binding density (ligand bound/bp) would be 0.12 or six molecules on the 50-bp sequence.
Similarly, we can identify 22 out of 50 bp protected by the intercalator actinomycin, which corresponds to 44% saturation (Fig. 10) . Of the 22 bp protected by actinomycin, 15 bp (68%) are dG-dC. The minimum protected region observed is the 3-bp sequence, 5' GTG 3'. For a binding-site size of 3 or 4 bp, the binding density for actinomycin would be 0.15-0.11 or approximately six to seven molecules on the 50-bp sequence. It is difficult at this time to determine whether this is a reasonable estimate. Two closely spaced but not contiguous ligands could exclude MPE cleavage between them. Therefore, fewer molecules could appear to provide a larger protected region. Alternatively, one could imagine unsymmetrical ligand binding where the tether-EDTA is able to oxidize the deoxyribose moiety more efficiently on one side of the ligand. In this case a somewhat larger number of bound molecules could afford a smaller protected region than expected.
In summary, complementary-strand analyses of distamycin-and actinomycin-binding sites on DNA support the asymmetric model for MPE.Fe(II) footprinting. The footprints appear to be shifted 1-2 bp to the 3' side on each strand and are 1 bp underprotected on the 5' side. With this model in hand, we expect to define more precisely the binding sites of small molecules on native DNA and to interpret more correctly singlestrand analyses on other DNA restriction fragments.
